NATCO Pharma announced that it has obtained approval for its ANDA concerning Everolimus tablets for oral suspension (TFOS), a generic equivalent of AFINITOR DISPERZ from Novartis Pharmaceutical Corporation. Breckenridge Pharmaceutical, Inc, the...
Neurocrine Biosciences, Inc., a prominent biopharmaceutical firm concentrating on neuroscience, revealed the commencement of a phase 3 trial to assess the efficacy, safety, and tolerability of osavampator (previously known as NBI-1065845)...
Beckman Coulter Diagnostics, a worldwide frontrunner in clinical diagnostics, declared that the US Food and Drug Administration (FDA) has awarded Breakthrough Device Designation to Beckman Coulter's Access p-Tau217/ß-Amyloid 1-42 plasma ratio...
Global pharmaceutical giant Lupin Limited has revealed that it has gained approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Ipratropium Bromide Nasal Solution (Nasal Spray)...
Syensqo, a top international provider of advanced performance materials and chemical solutions, and MezLight LLC, experts in medical device solutions, have partnered to introduce a groundbreaking surgical lighting system to the market that...
TME Pharma N.V., a biotechnology firm in the clinical stage dedicated to creating innovative cancer therapies that target the tumor microenvironment (TME), revealed a partnership with aimed analytics, an advanced medical data analytics company...
Argonaut Manufacturing Services, a contract development and manufacturing organization catering to the biopharma and life sciences sectors, has been chosen as the manufacturing partner for Akoya Biosciences Inc.’s IVD assays that are under...
Global pharmaceutical giant Lupin Limited (Lupin) and Avas Pharmaceuticals SRL (Avas), a prominent pharmaceutical firm recognized for its proficiency in marketing branded drugs, declared the introduction of Lupin’s orphan medication NaMuscla...
The U.S. Food and Drug Administration (FDA) has approved 510(k) clearance for Fresenius Kabi’s Adaptive Nomogram, a different algorithm to be included in the Aurora Xi Plasmapheresis System aimed at enhancing plasma collection efficiency...
Lantern Pharma has introduced a novel artificial intelligence (AI)-driven tool aimed at enhancing the accuracy, affordability, and speed of antibody-drug conjugates (ADCs) development for cancer. The AI company listed on Nasdaq is enhancing the...
, CDSCO.jpg)
